for its Abbreviated New Drug Application (ANDA) for ipratropium bromide nasal solution (nasal spray), 0.06%, to market a generic equivalent of Atrovent nasal spray, 0.06%, of Boehringer Ingelheim ...

Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma. Design: Multicentre ...

has accepted for review the New Drug Application (NDA) for its novel Bumetanide Nasal Spray (RSQ-777). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of September 14, ...

He had no known drug allergies. Social history was pertinent ... His medication list included albuterol, budesonide-formoterol inhaler, fluticasone nasal spray, montelukast, tiotropium bromide ...

has accepted for review the New Drug Application (NDA) for its novel Bumetanide Nasal Spray (RSQ-777). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of September ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

The FDA's expanded approval will allow the drug to be more accessible with insurance. Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients ...

A Clare County man accused of domestic violence and drug crimes faces a preliminary ... While there were no injuries reported from the spray, deputies found a methamphetamine pipe in plain view ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...